Their own payment-practices filing · gov.uk
Genome Research Limited pays suppliers in 20 days on average — inside its 30-day stated terms
Their H1 2026 filing puts the average 10 days inside their stated 30-day term.
- Their stated terms
- 30 days
- Paid outside agreed terms
- 16% of invoices
- Paid after 61+ days
- 0%
- Reporting period
- 1 Oct 2025 – 31 Mar 2026
- Source
- their gov.uk filing, filed 30 Apr 2026
Self-reported figures from their statutory filing. How this is compiled.
Terms vs reality · their H1 2026 filing
Paid 10 days inside the 30-day term they state
Where their invoices landed · share of all invoices
The pattern · last 6 of 17 reports
24 → 20 days — getting faster
The read · computed from their figures
Genome Research Limited's H1 2026 filing puts their average at 20 days against stated terms of 30 days; 16% of invoices were paid outside agreed terms and 0% took 61 days or longer. Filed 30 Apr 2026.
The direction is faster: from 24 days in H2 2023 to 20 now — 4 days faster across their last 6 reports.
On the latest reported averages: Faster than 80% of the 510 large companies reporting in professional & technical services.
That is 17 statutory periods on record (earliest H1 2018) — a historical record, not a promise for a new invoice.
What they tell their suppliers
In their own words · from the filing
Standard payment terms
30 days after receipt of invoice subject to goods having been delivered to the Company’s satisfaction
Dispute resolution
The company attempt in good faith to resolve any dispute promptly through negotiations between representatives of the supplier and company staff who have appropriate authority
Every statutory report on record
Most recent first.
| Period | Avg days | Outside terms | 61+ days | Filed |
|---|---|---|---|---|
| H1 2026 | 20 | 16% | 0% | 30 Apr 2026 |
| H2 2025 | 21 | 11% | 1% | 27 Oct 2025 |
| H1 2025 | 21 | 10% | 1% | 7 May 2025 |
| H2 2024 | 21 | 1% | 1% | 30 Oct 2024 |
| H1 2024 | 22 | 30% | 1% | 30 Apr 2024 |
| H2 2023 | 24 | 30% | 2% | 20 Nov 2023 |
| H1 2023 | 23 | 33% | 2% | 18 Apr 2023 |
| H2 2022 | 28 | 35% | 3% | 27 Oct 2022 |
| H1 2022 | 32 | 56% | 4% | 27 Apr 2022 |
| H2 2021 | 26 | 0% | 3% | 10 Nov 2021 |
| H1 2021 | 25 | 4% | 2% | 19 Apr 2021 |
| H2 2020 | 20 | 8% | 3% | 29 Oct 2020 |
| H1 2020 | 22 | 1% | 1% | 23 Apr 2020 |
| H2 2019 | 19 | 12% | 2% | 28 Oct 2019 |
| H1 2019 | 14 | 5% | 1% | 30 Apr 2019 |
| H2 2018 | 13 | 0% | 1% | 23 Oct 2018 |
| H1 2018 | 18 | 1% | 2% | 23 Apr 2018 |
On the public register · Companies House
Company record
- Status
- Active
- Type
- PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
- Incorporated
- 20 Aug 1992
- Registered office
- WELLCOME SANGER INSTITUTE WELLCOME GENOME CAMPUS, SAFFRON WALDEN, CB10 1SA
Quick answers · Genome Research Limited
Are they getting slower or faster?
What's their typical pay point?
Can I see what this means for my invoices?
Stay ahead
Watch Genome Research Limited (free)
Their next payment report is due ≈ 27 Oct 2026. We watch their public record and email you when something changes — a new payment report, late filings, insolvency markers, new charges.
You’ll get a confirmation email first. Unsubscribe any time. How we handle your address.
More large companies in professional & technical services
Genesis Oil & Gas Consultants Limited · Genus Breeding Limited · Ge Energy Power Conversion Technology Limited · Genzyme Therapeutics Limited · Gateley PLC · GFK U.K. Limited
How UK payment reporting works
What is a Payment Practices Report?
What does "paid outside agreed terms" mean?
How often is this data updated?
Is this official government data?
How this is compiled. Built from official records only: Companies House and the gov.uk payment-practices service. The payment figures are self-reported — companies over the size threshold must file them by law and the board signs them off. No credit-agency data. The numbers are theirs; the plain-English read is ours. This is information compiled from public records under the Open Government Licence v3.0 — not a credit rating and not advice.
The 31-day comparison figure is the median across 6,104 companies with a current statutory report — every sector pooled, not an average of sector medians (how the figure is built).
Report PL-02742969 · latest period to 31 Mar 2026
Built by YORXEN LTD · registered in England & Wales · CRN 17303256 · privacy · terms.